Welcome to the detailed analysis for endpoints.news. This domain is officially recognized as Endpoints News – Biotech and pharma business news, with a focus on the science, people and money that drive the industry.. According to their official web presence, their primary focus is: "Biotech and pharma business news, with a focus on the science, people and money that drive the industry.".
"Fresenius Kabi will sell biosimilars directly to employers."
"Biohaven has found a commercial partner for its late-stage epilepsy drug."
"The FDA approved AbbVie’s tavapadon, a next-generation therapy for Parkinson’s disease that's expected to provide the symptom relief of its predecessors but with fewer side effects."
"The many Novo investors hoping for a transformative deal will have to content themselves with another small development pact."
By comparing endpoints.news to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to endpoints.news.
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
As of September 30, 2026, endpoints.news holds an estimated domain authority score of 71/100 based on our VisitRank tracking algorithms.
You can find the best alternatives and similar sites to endpoints.news in our explore section, which includes competitors in the E-commerce & Retail sector.
Common Misspellings & Typo Domains for endpoints.news: